Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Masimo Corp (MASI)

Masimo Corp (MASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,018,220
  • Shares Outstanding, K 53,337
  • Annual Sales, $ 858,290 K
  • Annual Income, $ 193,540 K
  • 60-Month Beta 1.13
  • Price/Sales 10.54
  • Price/Cash Flow 47.25
  • Price/Book 8.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.87
  • Number of Estimates 3
  • High Estimate 0.87
  • Low Estimate 0.87
  • Prior Year 0.83
  • Growth Rate Est. (year over year) +4.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
155.67 +8.61%
on 01/06/20
175.25 -3.52%
on 01/22/20
+9.69 (+6.08%)
since 12/24/19
3-Month
140.53 +20.32%
on 11/06/19
175.25 -3.52%
on 01/22/20
+26.55 (+18.63%)
since 10/24/19
52-Week
118.93 +42.17%
on 04/18/19
175.25 -3.52%
on 01/22/20
+47.76 (+39.37%)
since 01/24/19

Most Recent Stories

More News
COPD Devices Gain Regulatory Go-Ahead: 3 Stocks in Focus

Growth in the COPD devices market can be attributed to factors like steadily rising geriatric population, increasing incidence of smoking and chronic respiratory diseases.

PHG : 50.08 (+0.36%)
MASI : 169.08 (-0.54%)
RMD : 162.39 (+0.62%)
BSX : 43.21 (-0.83%)
Masimo Corp Rises 1.25% on Heavy Volume: Watch For Potential Pullback

Masimo Corp (NASDAQ:MASI) traded in a range yesterday that spanned from a low of $169.20 to a high of $172.14. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of...

MASI : 169.08 (-0.54%)
Masimo Posts Solid Preliminary 2019 Results, Issues Guidance

Higher revenues and upbeat 2020 outlook benefit Masimo's (MASI) preliminary full-year 2019 results.

MASI : 169.08 (-0.54%)
XRAY : 59.66 (unch)
PDCO : 23.35 (-0.81%)
WST : 155.75 (-0.51%)
Depth of Anesthesia Monitoring Markets, Forecast to 2025 - Leading Players are GE Healthcare, Medtronic, Koninklijke Philips, OSI Systems, and Masimo Corp

The "Global Depth of Anesthesia Monitoring Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

MASI : 169.08 (-0.54%)
Masimo Announces Select Preliminary Full-Year 2019 Financial Results and 2020 Guidance

Masimo Corporation (NASDAQ: MASI) today announced select preliminary results for the full-year ended December 28, 2019 and provided estimates for its full-year 2020 financial guidance.

MASI : 169.08 (-0.54%)
Masimo to Acquire Connected Care Business from NantHealth

Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, and NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the...

NH : 1.36 (-2.16%)
MASI : 169.08 (-0.54%)
Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod

Masimo (MASI) will cater to the whole prenatal patient population, with the recent FDA clearance within the SET pulse oximetry business.

MASI : 169.08 (-0.54%)
MDT : 119.26 (-1.41%)
HAE : 107.45 (-2.37%)
EYE : 36.76 (+3.35%)
Masimo Announces FDA Clearance for Neonatal RD SET(R) Pulse Oximetry Sensors with Improved Accuracy Specifications

Masimo (NASDAQ: MASI) announced today that RD SET(R) sensors with Masimo Measure-through Motion and Low Perfusion(TM) SET(R) pulse oximetry have received FDA clearance for improved oxygen saturation (SpO2)...

MASI : 169.08 (-0.54%)
Here's Why You Should Hold on to Masimo (MASI) Stock Now

Masimo (MASI) raises revenue and earnings guidance for 2019.

MASI : 169.08 (-0.54%)
WST : 155.75 (-0.51%)
CNMD : 108.00 (-0.63%)
HQY : 70.58 (-1.64%)
Masimo (MASI) Expands Partnership with Texas-Based Drager

Masimo (MASI) sees a slew of developments in recent times.

MASI : 169.08 (-0.54%)
WST : 155.75 (-0.51%)
CNMD : 108.00 (-0.63%)
HQY : 70.58 (-1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MASI with:

Business Summary

Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare...

See More

Key Turning Points

2nd Resistance Point 171.43
1st Resistance Point 170.26
Last Price 169.08
1st Support Level 168.14
2nd Support Level 167.19

See More

52-Week High 175.25
Last Price 169.08
Fibonacci 61.8% 153.74
Fibonacci 50% 147.09
Fibonacci 38.2% 140.44
52-Week Low 118.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar